These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35595945)

  • 81. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer.
    Yang X; Ye T; Liu H; Lv P; Duan C; Wu X; Jiang K; Lu H; Xia D; Peng E; Chen Z; Tang K; Ye Z
    Mol Cancer; 2021 Jan; 20(1):4. PubMed ID: 33397425
    [TBL] [Abstract][Full Text] [Related]  

  • 83. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Diagnostic accuracy of circulating exosomal circRNAs in malignances: A meta-analysis and systematic review.
    Yuan X; Mao Y; Ou S
    Medicine (Baltimore); 2023 May; 102(21):e33872. PubMed ID: 37233410
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Abnormally expressed circular RNAs as novel non-invasive biomarkers for hepatocellular carcinoma: A meta-analysis.
    Jiang YL; Shang MM; Dong SZ; Chang YC
    World J Gastrointest Oncol; 2019 Oct; 11(10):909-924. PubMed ID: 31662829
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis.
    Vsiansky V; Gumulec J; Raudenska M; Masarik M
    Sci Rep; 2018 Jul; 8(1):10370. PubMed ID: 29991692
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Prediction of a 3-Protein-Based Model on the Prognosis of Head and Neck Squamous Cell Carcinoma.
    Chen X; Wong K; Li Y; Guan Z
    Comput Math Methods Med; 2022; 2022():2161122. PubMed ID: 35756403
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
    Zhang M; Wen F; Zhao K
    J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tumor budding is a prognostic factor in head and neck squamous cell carcinoma: A comprehensive meta-analysis and trial sequential analysis.
    Silva FFVE; Caponio VCA; Pérez-Sayáns M; Padín-Iruegas ME; Mascitti M; Chamorro-Petronacci CM; Suaréz-Peñaranda JM; Lorenzo-Pouso AI
    Crit Rev Oncol Hematol; 2024 Jan; 193():104202. PubMed ID: 37989426
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological Factors.
    Rochow H; Jung M; Weickmann S; Ralla B; Stephan C; Elezkurtaj S; Kilic E; Zhao Z; Jung K; Fendler A; Franz A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105568
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Diagnostic Accuracy of circRNAs in Esophageal Cancer: A Meta-Analysis.
    Niu C; Zhao L; Guo X; Shen Y; Shao Y; Liu F
    Dis Markers; 2019; 2019():9673129. PubMed ID: 31534563
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma.
    Zhao C; Wei C; Chen X; Li P
    Biomed Res Int; 2022; 2022():7281120. PubMed ID: 35924262
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Identification of Novel Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma using Bioinformatics Analysis.
    Ding Y; Li M; Tayier T; Chen L; Feng S
    Comb Chem High Throughput Screen; 2021; 24(9):1351-1363. PubMed ID: 33109035
    [TBL] [Abstract][Full Text] [Related]  

  • 95. DNA methylation biomarkers for head and neck squamous cell carcinoma.
    Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H
    Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.
    Wu XL; Tu Q; Faure G; Gallet P; Kohler C; Bittencourt Mde C
    Sci Rep; 2016 Feb; 6():20210. PubMed ID: 26831813
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Significance of circRNAs as biomarkers for systemic lupus erythematosus: a systematic review and meta-analysis.
    Wang L; Lu M; Li W; Fan R; Wen S; Xiao W; Lin Y
    J Int Med Res; 2022 Jul; 50(7):3000605221103546. PubMed ID: 35796516
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
    Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
    Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications.
    Cen WN; Pang JS; Huang JC; Hou JY; Bao WG; He RQ; Ma J; Peng ZG; Hu XH; Ma FC
    Pathol Res Pract; 2018 Nov; 214(11):1835-1847. PubMed ID: 30243807
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
    Hu C; Fan J; He G; Dong C; Zhou S; Zheng Y
    PLoS One; 2022; 17(6):e0269166. PubMed ID: 35653344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.